NF-κB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells

被引:46
|
作者
Kim, JO
Kim, HW
Baek, KM
Kang, CY [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Immunol Lab, Seoul 151742, South Korea
[2] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 151742, South Korea
关键词
4-1BB; CD137; T cell activation; T cell receptor signal; transcription factor;
D O I
10.1016/S0014-5793(03)00326-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-1BB(CD137) is a member of the tumor necrosis factor receptor superfamily and provides a costimulatory signal by interaction with 4-1BB ligand expressed on antigen-presenting cells. The expression of 4-1BB is known to be activation-dependent. Here, we investigated the transcriptional machinery required for T cell receptor (TCR) activation-dependent induction of 4-1BB expression in CD3-CEM cells treated with phorbol myristate acetate and ionomycin. Using 5'-deletion constructs of 4-1BB promoter in luciferase reporter assays, we demonstrated that the transcriptional elements mediating 4-1BB upregulation were located in the region between similar to 0.9 and similar to 1.1 kb from the translational start site. Characterization of these sites by electrophoretic mobility shift assay and site-directed mutagenesis revealed that nuclear factor kappaB (NF-kappaB) and activating protein-1 (AP-1) are involved. MEK and c-Jun N-terminal kinase-1 activity was required for activation-dependent 4-1BB upregulation. Thus, NF-kappaB and AP-1 are involved in the TCR stimulation-dependent transcriptional regulation of the 4-1BB promoter. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [1] NF-κB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells
    Kim, JO
    Kim, HW
    Baek, KM
    Kang, CY
    FASEB JOURNAL, 2003, 17 (07): : C97 - C97
  • [2] Functional expression of CD137 (4-1BB) on T helper follicular cells
    Alfaro, Carlos
    Echeveste, Jose I.
    Rodriguez-Ruiz, Maria E.
    Solorzano, Jose L.
    Perez-Gracia, Jose L.
    Idoate, Miguel A.
    Lopez-Picazo, Jose M.
    Sanchez-Paulete, Alfonso R.
    Labiano, Sara
    Rouzaut, Ana
    Onate, Carmen
    Aznar, Angela
    Lozano, Maria D.
    Melero, Ignacio
    ONCOIMMUNOLOGY, 2015, 4 (12):
  • [3] Expression of CD137 (4-1BB) on human follicular dendritic cells
    Lindstedt, M
    Johansson-Lindbom, B
    Borrebaeck, CAK
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (04) : 305 - 310
  • [4] CD137 (4-1BB) and T-Lymphocyte Exhaustion
    Molero-Glez, Paula
    Azpilikueta, Arantza
    Mosteo, Laura
    Glez-Vaz, Javier
    Palencia, Belen
    Melero, Ignacio
    CLINICAL CANCER RESEARCH, 2024, 30 (18) : 3971 - 3973
  • [5] 4-1BB (CD137) in anticancer chimeras
    Melero, Ignacio
    Berraondo, Pedro
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (12):
  • [6] Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells
    Salih, HR
    Kosowski, SG
    Haluska, VF
    Starling, GC
    Loo, DT
    Lee, F
    Aruffo, AA
    Trail, PA
    Kiener, PA
    JOURNAL OF IMMUNOLOGY, 2000, 165 (05): : 2903 - 2910
  • [7] Expression and regulation of ILA (human 4-1BB/CD137) in B cell lines
    vonKempis, J
    Kienzle, G
    Braun, M
    Illges, H
    Peter, HH
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 55 - 55
  • [8] The therapeutic potential of 4-1BB (CD137) in cancer
    Nam, KO
    Kang, WJ
    Kwon, BS
    Kim, SJ
    Lee, HW
    CURRENT CANCER DRUG TARGETS, 2005, 5 (05) : 357 - 363
  • [9] Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
    Kim, YJ
    Brutkiewicz, RR
    Broxmeyer, HE
    BLOOD, 2002, 100 (09) : 3253 - 3260
  • [10] Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival
    Cho, HR
    Kwon, B
    Yagita, H
    La, S
    Lee, EA
    Kim, JE
    Akiba, H
    Kim, J
    Suh, JH
    Vinay, DS
    Ju, SA
    Kim, BS
    Mittler, RS
    Okumura, K
    Kwon, BS
    TRANSPLANT INTERNATIONAL, 2004, 17 (07) : 351 - 361